(Q38010180)

English

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PI3Kδ inhibitors in cancer: rationale and serendipity merge in the clinic (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

author name string

David A Fruman

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Christian Rommel

2

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

publication date

29 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Cancer Discovery

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

562-572

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Mutant PIK3CA promotes cell growth and invasion of human cancer cells

1 reference

24 May 2022

https://opencitations.net/index/coci/api/v1/citations/10.1016/J.CCR.2005.05.014

Identifiers

10.1158/2159-8290.CD-11-0249

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38010180&oldid=1737229629"